- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07316647
Using Conversational AI to Teach Growth Mindset Skills to Youths in India
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Globally, 300 million youths have a diagnosable mental disorder and more reside in India than any other country. Yet, in India, where this study is based, most youths affected by mental health issues do not receive treatment. Symptoms are especially prevalent during high school, when many students show signs of depression and anxiety. Given myriad challenges in accessing mental healthcare, some have turned to conversational AIs such as ChatGPT and Claude for personalized support. However, there are few rigorous tests of whether such tools can improve mental health.
This study aims to bridge this gap by combining conversational AI with evidence-based intervention for youth mental health-specifically, a growth mindset intervention, which promotes the belief that abilities are not innate but can be improved with effort. It is well known that growth mindset interventions can improve academic performance. In addition, researchers have shown that brief, computer-guided growth mindset training can reduce symptoms of anxiety and depression that sustain 3-9 months post-intervention, and not only in the United States. However, until now, these interventions have been delivered via static, standardized websites that few people use.
The intervention considered is a 45-minute interactive lesson on growth mindset, embedded within a conversational AI. Similar to prior interventions, the content includes modules on understanding growth mindset, its basis in neuroplasticity, and roleplaying scenarios. Each module includes interactive discussions with the AI (e.g., "in your words, what is a growth mindset?", "in the above scenario, how could a growth mindset apply?")
The specific aim of the study is to test whether a brief, AI-enabled growth mindset intervention offers measurable benefits for school-aged youth in India. A randomized controlled trial with about 430 students (grades 6-8) will measure whether the AI-enabled training leads to changes in growth mindset beliefs and skills as well as symptoms of anxiety and depression, relative to a control group that receives a shortened intervention after 7 weeks. Brief, 10-minute questionnaires will be administered to all participants at baseline, 3 weeks, and 7 weeks. At the conclusion of the trial, all students will receive a printed booklet with content from the full intervention. The study will take place in an English-medium private school in Bangalore, India, which serves a diversity of students.
The growth mindset intervention may also benefit academic performance, and the school partner, at its discretion, may be able to integrate it into part of their standard curriculum following the completion of the study. However, the specific research question is whether the chatbot interaction yields measurable improvements in youth mental health. Given the preponderance of AI chatbots aiming to address various aspects of mental health, such measurement is as important as it is rare. This study will contribute to the growing evidence base on how technology can inform and support youth mental health.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Karnataka
-
Bangalore, Karnataka, India
- Partner school
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Youth in grades 6-8 at our partner school
- Youth assents to participate and a parent/guardian provides passive consent (does not opt-out of participation)
Exclusion Criteria:
- N/A
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Growth mindset training
Receives growth mindset training via 45-minute interaction with conversational AI
|
Participants will interact with an AI chatbot for approximately 45 minutes.
The tutorial has a structured script and pauses at section boundaries to allow for brief interactions.
It also contains culturally-grounded comics and illustrations with role-playing scenarios to engage with students.
|
|
No Intervention: Usual classroom activities
Performs usual classroom activities during the intervention period; receives delayed and shortened intervention at the conclusion of the study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Behavior and Feelings Survey - Internalizing Subscale (full sample)
Time Frame: Baseline, 3 weeks, 7 weeks
|
Trajectories of self-reported symptoms of anxiety and depression from the 6-item (each item rated on a 0-4 scale, with higher ratings indicating more symptoms) Internalizing Subscale of the Behavior and Feelings Survey.
Total scores range from 0 to 24, with higher scores indicating more symptoms (BFS; Weisz et al., 2020).
|
Baseline, 3 weeks, 7 weeks
|
|
Student Perceived Program Acceptability and Helpfulness
Time Frame: Immediately post-intervention
|
Assessed via the Program Feedback Scale (Schleider et al., 2019).
This scale consists of 7 items rated on a 1 to 5 scale, with higher scores indicating greater acceptability and helpfulness.
|
Immediately post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Behavior and Feelings Survey - Internalizing Subscale (elevated subsample)
Time Frame: Baseline, 3 weeks, 7 weeks
|
Trajectories of self-reported symptoms of anxiety and depression from the 6-item (each item rated on a 0-4 scale, with higher ratings indicating more symptoms) Internalizing Subscale of the Behavior and Feelings Survey.
Total scores range from 0 to 24, with higher scores indicating more symptoms (BFS; Weisz et al., 2020).
|
Baseline, 3 weeks, 7 weeks
|
|
Change in Growth Mindset Beliefs (full sample and elevated subsample)
Time Frame: Baseline, 3 weeks, 7 weeks
|
Assessed via the Growth Mindset Scale (Sigmundsson & Haga, 2024), adapted to a lower reading level.
This scale consists of 8 items, rated on a scale from 1 (not like me at all) to 5 (very much like me).
|
Baseline, 3 weeks, 7 weeks
|
|
Growth mindset reflections (intervention group)
Time Frame: 3 weeks, 7 weeks
|
Assessed with brief questions to check recall and use of growth mindset as well as intent to apply it in the future:
|
3 weeks, 7 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: John R Weisz, Ph.D., Harvard University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB25-0827
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on Growth mindset training using conversational AI
-
The Hong Kong Polytechnic UniversityThe First Affiliated Hospital of Soochow University; Second Affiliated Hospital... and other collaboratorsNot yet recruitingColorectal Cancer (CRC)China
-
University of CopenhagenCompletedArtificial Intelligence | EducationDenmark
-
Corina Schuster-AmftCompleted
-
National Cancer Institute (NCI)NSABP Foundation IncCompletedColon Adenocarcinoma | Stage IIIA Colon Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage IIIC Colon Cancer AJCC v7 | Stage IIA Colon Cancer AJCC v7 | Stage IIB Colon Cancer AJCC v7 | Stage IIC Colon Cancer AJCC v7United States
-
National Cancer Institute (NCI)CompletedRectal Adenocarcinoma | Stage III Rectal Cancer AJCC v7 | Stage II Rectal Cancer AJCC v7United States